{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:06:52Z","timestamp":1770977212644,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bjid.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T18:00:10Z","timestamp":1511373610000},"page":"37-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Galactomannan use in clinical practice: providing free testing is not the full answer"],"prefix":"10.1016","volume":"22","author":[{"given":"Jeniffer S.","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djuli M.","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro C.","family":"Pasqualotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.11.002_bib0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/atm.2016.08.32","article-title":"The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"4","author":"Hites","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bjid.2017.11.002_bib0080","article-title":"Empiric antibiotic protocols for cancer patients with neutropenia: a single center study of treatment efficacy and mortality in patients with bacteremia","author":"Kleinhendler","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2017.11.002_bib0085","series-title":"Microbiologia M\u00e9dica e Imunologia","first-page":"404","author":"Levinson","year":"2016"},{"key":"10.1016\/j.bjid.2017.11.002_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mould infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2017.11.002_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/S0037-86822011000100030","article-title":"Aspergilose pulmonar em paciente imunocompetente e previamente sadio","volume":"44","author":"Mendon\u00e7a","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bjid.2017.11.002_bib0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.arbres.2015.02.010","article-title":"Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses","volume":"51","author":"Curbelo","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.bjid.2017.11.002_bib0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3346\/jkms.2015.30.8.1121","article-title":"Clinical features and prognosis of invasive pulmonary aspergillosis in Korean children with hematologic\/oncologic diseases","volume":"30","author":"Han","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.bjid.2017.11.002_bib0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1590\/S1413-86702008000500008","article-title":"Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis","volume":"12","author":"Dias","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.002_bib0115","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1590\/S1806-37132009001200012","article-title":"Aspergilose: do diagn\u00f3stico ao tratamento","volume":"35","author":"Sales","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.bjid.2017.11.002_bib0120","article-title":"Challenges in microbiological diagnosis of invasive Aspergillus infections","volume":"17","author":"Alanio","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.bjid.2017.11.002_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0123-9392(10)70131-4","article-title":"Actualizaci\u00f3n em Aspergilosis con \u00e9nfasis en Aspergilosis invasora","volume":"14","author":"Maldonado","year":"2010","journal-title":"Infect"},{"key":"10.1016\/j.bjid.2017.11.002_bib0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.002_bib0135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.002_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017308309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017308309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T18:08:54Z","timestamp":1535220534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867017308309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1413867017308309"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.11.002","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galactomannan use in clinical practice: providing free testing is not the full answer","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}